Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$382M |
| 2 |
Pfizer
PFE
|
+$266M |
| 3 |
EA
Electronic Arts
EA
|
+$240M |
| 4 |
Eli Lilly
LLY
|
+$221M |
| 5 |
Colgate-Palmolive
CL
|
+$216M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booking.com
BKNG
|
+$358M |
| 2 |
Comcast
CMCSA
|
+$263M |
| 3 |
Meta Platforms (Facebook)
META
|
+$258M |
| 4 |
AET
Aetna Inc
AET
|
+$257M |
| 5 |
Tesla
TSLA
|
+$189M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.13% |
| 2 | Technology | 13.55% |
| 3 | Financials | 11.85% |
| 4 | Consumer Staples | 10.18% |
| 5 | Industrials | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DDC
551
DELISTED
Dominion Diamond Corporation
DDC
| $33.6M | 0.04% |
2,673,198
+21,800
| +0.8% | +$277K |
|
552
Gold Fields
GFI
$35.4B
| $33.5M | 0.04% |
9,624,100
-1,921,900
| -17% | -$6.95M |
|
553
Adtran
ADTN
$658M
| $33.5M | 0.04% |
1,620,128
+328,600
| +25% | +$6.58M |
|
554
Check Point Software Technologies
CHKP
$13.7B
| $33.4M | 0.04% |
306,300
-25,908
| -8% | -$2.8M |
|
555
Central Garden & Pet Co Class A
CENTA
$2.41B
| $33.4M | 0.04% |
1,391,125
+52,750
| +4% | +$1.35M |
|
|
WMGI
556
DELISTED
Wright Medical Group Inc
WMGI
| $33.2M | 0.04% |
1,209,407
+705,300
| +140% | +$19.9M |
|
557
Rambus
RMBS
$10.8B
| $33.2M | 0.04% |
2,908,586
+832,386
| +40% | +$10.2M |
|
558
International Paper
IP
$21.8B
| $33.2M | 0.04% |
619,661
+467,069
| +306% | +$23.6M |
|
559
AGNC Investment
AGNC
$13B
| $33.2M | 0.04% |
1,558,929
+1,333,368
| +591% | +$27.7M |
|
560
Cooper Companies
COO
$14.9B
| $33.2M | 0.04% |
554,000
-211,992
| -28% | -$11.5M |
|
|
PSB
561
DELISTED
PS Business Parks, Inc.
PSB
| $33.1M | 0.04% |
249,900
-23,900
| -9% | -$2.98M |
|
|
TIME
562
DELISTED
Time Inc.
TIME
| $33.1M | 0.04% |
2,305,400
-181,900
| -7% | -$2.72M |
|
|
PINC
563
DELISTED
Premier
PINC
| $32.9M | 0.04% |
914,100
+89,500
| +11% | +$3.06M |
|
564
Keysight
KEYS
$60.5B
| $32.9M | 0.04% |
845,200
+456,200
| +117% | +$17.2M |
|
565
Verisk Analytics
VRSK
$24.2B
| $32.6M | 0.04% |
386,700
-133,000
| -26% | -$10.8M |
|
|
EMBJ
566
Embraer S.A. ADS
EMBJ
$13.2B
| $32.6M | 0.04% |
1,789,000
+295,500
| +20% | +$5.81M |
|
567
Rogers Corp
ROG
$2.46B
| $32.5M | 0.04% |
299,300
+44,900
| +18% | +$4.55M |
|
568
Infosys
INFY
$50.3B
| $32.4M | 0.04% |
+4,318,600
| New | +$32.3M |
|
569
Cenovus Energy
CVE
$56.4B
| $32.4M | 0.04% |
4,392,500
+3,388,200
| +337% | +$31.4M |
|
|
DOOR
570
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $32.4M | 0.04% |
428,700
-84,037
| -16% | -$6.45M |
|
|
MGI
571
DELISTED
MoneyGram International, Inc. New
MGI
| $32.3M | 0.04% |
1,875,291
+462,900
| +33% | +$7.98M |
|
572
Shenandoah Telecom
SHEN
$744M
| $32.3M | 0.04% |
1,052,800
+6,500
| +0.6% | +$201K |
|
573
Comfort Systems
FIX
$60.8B
| $32.2M | 0.04% |
868,092
+90,592
| +12% | +$3.22M |
|
|
CNH
574
CNH Industrial
CNH
$16.7B
| $32.2M | 0.04% |
3,260,937
+247,432
| +8% | +$2.33M |
|
575
Philips
PHG
$26.8B
| $32.2M | 0.04% |
1,182,871
+73,639
| +7% | +$1.93M |
|
Similar funds
Jim Simons's Q2 2017 Portfolio in Review
As of Q2 2017, Jim Simons held 3,586 positions worth $78.4B, up 9.5% from $71.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
Jim Simons deployed $4.59B of net new capital in Q2 2017, opening 398 new positions and adding to 1,648 existing holdings. Its largest new stake was Pfizer: 8,421,609 shares worth $268M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Comcast, an estimated $263M trimmed.
- Jim Simons's largest Q2 2017 buy was Pfizer: 8,421,609 shares worth $268M.
- Jim Simons added most to Bristol-Myers Squibb in Q2 2017, an estimated $382M increase.
- Jim Simons's biggest Q2 2017 reduction was Comcast, cutting an estimated $263M.
- Jim Simons fully exited Booking.com in Q2 2017, selling an estimated $358M.
- Jim Simons's ten largest holdings make up 9% of its $78.4B portfolio in Q2 2017.
- Jim Simons opened 398 new positions and closed 418 in Q2 2017.
- Jim Simons's portfolio value rose 9.5% quarter-over-quarter to $78.4B.
Based on Renaissance Technologies's 13F filing for Q2 2017, filed 11 Aug 2017.